Genetic variation associated with thyroid autoimmunity shapes the systemic immune response to PD-1 checkpoint blockade

Autor: Christian Hammer, Sergio Ley Acosta, Matthew L. Albert, Julie Hunkapiller, J. D. Carroll, Chandler Gs, Tushar Bhangale, Ira Mellman, Di Nucci F, Zia Khan, Mark I McCarthy, Maiya

Publikováno v: Nature Communications
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)

Activation of systemic immune responses using PD-1 checkpoint inhibitors is an essential approach to cancer therapy. Yet, the extent of benefit relative to risk of immune related adverse events (irAE) varies widely among patients. Here, we study endo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f68077b105fa838ab15c65a5b902caa
http://europepmc.org/articles/PMC8184890

Safety and tolerability of atezolizumab (atezo) plus bevacizumab (bev) vs sunitinib (sun) in untreated metastatic renal cell carcinoma (mRCC): Pooled analysis of IMmotion150 and IMmotion151

Autor: Suarez, Cristina, Choueri, T.K., McDermott, D.F., Escudier, B., Atkins, M.B., Powles, T.B., Rini, B.I., Motzer, R.J., PAL, S.K., Fong, L., De Giorgi, Ugo, Wang, Y., Khaznadar, Tarik, Di Nucci, F., Kaiser, C., Tayama, D., Donskov, Frede

Publikováno v: Suarez, C, Choueri, T K, McDermott, D F, Escudier, B, Atkins, M B, Powles, T B, Rini, B I, Motzer, R J, PAL, S K, Fong, L, De Giorgi, U, Wang, Y, Khaznadar, T, Di Nucci, F, Kaiser, C, Tayama, D & Donskov, F 2018, ' Safety and tolerability of atezolizumab (atezo) plus bevacizumab (bev) vs sunitinib (sun) in untreated metastatic renal cell carcinoma (mRCC): Pooled analysis of IMmotion150 and IMmotion151. ', Annals of Oncology. Supplement, vol. 29, no. 8, pp. viii308 .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pure_au_____::ec39a6e6da0704d1982a0a0a57641ae0
https://pure.au.dk/portal/da/publications/safety-and-tolerability-of-atezolizumab-atezo-plus-bevacizumab-bev-vs-sunitinib-sun-in-untreated-metastatic-renal-cell-carcinoma-mrcc-pooled-analysis-of-immotion150-and-immotion151(e8f6dc5e-9062-445c-ae6c-e58f60e66303).html

872P - Phase Ib study (COSMIC-021) of cabozantinib in combination with atezolizumab: Results of the dose escalation stage in patients (pts) with treatment-naïve advanced renal cell carcinoma (RCC)

Autor: Agarwal, N., Vaishampayan, U., Green, M., di Nucci, F., Chang, P.-Y., Scheffold, C., Pal, S.

Publikováno v: In Annals of Oncology October 2018 29 Supplement 8

Effetti di un evento sismico sulle gallerie superficiali

Autor: Grisolia, Massimo, Iorio, G, DI NUCCI, F.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3686::423ef330b10f0aa77afd6f3f2cf1a21c
http://hdl.handle.net/11573/187386

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.